Showing 20 of 98 recruiting trials for “Squamous cell carcinoma of the esophagus”
Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC
A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]
👨⚕️ Lin Shen, Peking University Cancer Hospital & Institute📍 7 sites📅 Started Feb 2026View details ↗
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Vebrekotuzumab ± Anti-PD-1 in Pretreated Advanced ESCC
A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC
Perioperative Cadonilimab Combined With Neoadjuvant Chemotherapy in Resectable Esophageal Squamous Cell Carcinoma (ESCC)
👨⚕️ Xiaolong Yan, The Second Affiliated Hospital of Air Force Medical University📍 1 site📅 Started Dec 2025View details ↗
KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma
👨⚕️ Zhihao MM Lu, PHD, Peking University Cancer Hospital & Institute📍 1 site📅 Started Nov 2025View details ↗
Study of Tislelizumab Combined With Chemoradiotherapy and Surgery for Unresectable Esophageal Squamous Cell Carcinoma
The Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy as the First-line Treatment for Esophageal Squamous Cell Carcinoma
A Trial of the Combination of Afatinib and Palbociclib in Previously Treated Advanced Esophageal Squamous Cell Carcinoma
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
Neoadjuvant Immunochemotherapy and Chemoradiotherapy Followed by Surgery for Advanced Esophageal Squamous Cell Carcinoma
Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma
Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02)
Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinoma
MR-Guided Radiotherapy Dose Escalation Trial for Esophageal Squamous Cell Carcinoma
Page 1 of 5Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →